Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,384Revenue (TTM) $M161Net Margin (%)-62.4Altman Z-Score-3.3
Enterprise Value $M1,393EPS (TTM) $-0.7Operating Margin %-54.6Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.2Pre-tax Margin (%)-62.4Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio2.5Cash flow > EarningsY
Price/Sales7.35-y EBITDA Growth Rate %--Current Ratio2.5Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-527.3ROA % (ttm)-54.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M169ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with ARRY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARRYJoel Greenblatt 2016-09-30 Buy $3.17 - $6.75
($3.87)
$ 8.21112%New holding16,705
ARRYKen Fisher 2016-09-30 Add$3.17 - $6.75
($3.87)
$ 8.21112%Add 0.15%135,895
ARRYKen Fisher 2015-09-30 Buy $4.56 - $7.11
($5.94)
$ 8.2138%New holding135,695
ARRYFirst Eagle Investment 2011-12-31 Sold Out -0.0024%$1.77 - $2.83
($2.27)
$ 8.21262%Sold Out0
ARRYGeorge Soros 2011-12-31 Sold Out -0.0008%$1.77 - $2.83
($2.28)
$ 8.21260%Sold Out0
ARRYGeorge Soros 2011-09-30 Buy $1.99 - $2.62
($2.24)
$ 8.21267%New holding22,400
ARRYGeorge Soros 2011-06-30 Sold Out $2.06 - $3.21
($2.7)
$ 8.21204%Sold Out0
ARRYFirst Eagle Investment 2011-06-30 Add$2.06 - $3.21
($2.7)
$ 8.21204%Add 150.00%250,000
ARRYFirst Eagle Investment 2011-03-31 Buy $2.7 - $3.29
($3)
$ 8.21174%New holding100,000
ARRYGeorge Soros 2011-03-31 Buy $2.7 - $3.29
($3)
$ 8.21174%New holding14,400
ARRYFirst Eagle Investment 2010-09-30 Sold Out -0.01%$2.67 - $3.44
($3.02)
$ 8.21172%Sold Out0
ARRYFirst Eagle Investment 2010-06-30 Reduce-0.01%$2.66 - $4.02
($3.41)
$ 8.21141%Reduce -54.96%450,000
ARRYFirst Eagle Investment 2009-12-31 Add0.01%$1.72 - $2.81
($2.2)
$ 8.21273%Add 62.96%999,132
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARRY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ARRY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Redmile Group, LLC10% Owner 2016-09-28Sell2,492,578$6.3629.09view
Redmile Group, LLC10% Owner 2016-09-15Sell400,000$3.5134.57view
Redmile Group, LLC10% Owner 2016-09-15Buy400,000$3.51133.9view
Redmile Group, LLC10% Owner 2016-01-20Buy300,000$3.19157.37view
Redmile Group, LLC10% Owner 2016-01-12Buy75,000$3.6128.06view
Redmile Group, LLC10% Owner 2016-01-11Buy925,000$3.67123.71view
Redmile Group, LLC10% Owner 2015-10-01Buy782,592$4.5879.26view
Redmile Group, LLC10% Owner 2015-10-01Buy600,140$4.5879.26view
Redmile Group, LLC10% Owner 2015-08-26Buy49,900$5.4849.82view
Redmile Group, LLC10% Owner 2015-08-25Buy790,000$5.3852.6view

Quarterly/Annual Reports about ARRY:

News about ARRY:

Articles On GuruFocus.com
Screen: Stocks With Estimated Revenue Up 5% - January Jan 18 2016 
Insider Buys Round-up: Tenet Healthcare and Sprint Corp Aug 14 2015 
Novartis Gets FTC Nod To Buyout Glaxo Smithkline’s Cancer Drugs Feb 25 2015 
Can These Three BioTech Companies Make It Big? Feb 20 2015 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,310 Shares Mar 16 2011 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,403 Shares Feb 11 2011 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,272 Shares Jan 13 2011 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,256 Shares Dec 10 2010 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,220 Shares Nov 12 2010 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,225 Shares Oct 13 2010 

More From Other Websites
Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference Nov 22 2016
Is Redmile Group Right to Bet on Array Biopharma Inc (ARRY), Amicus Therapeutics, Inc. (FOLD) & Two... Nov 15 2016
Array Biopharma Inc (ARRY) Updates On COLUMBUS Phase 3 And It’s Impressive Nov 10 2016
Array Biopharma Inc (ARRY) Stock: Gaining Big On Clinical Data Nov 10 2016
ARRAY BIOPHARMA INC Financials Nov 09 2016
The Market Offers Some Opportunities but They're Disappearing Fast Nov 09 2016
ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 09 2016
COLUMBUS Phase 3 Study Results in BRAF-Mutant Melanoma Presented at Society for Melanoma Research... Nov 09 2016
Array BioPharma To Present At The Stifel 2016 Healthcare And Jefferies 2016 Global Healthcare... Nov 08 2016
7 Analyst Stocks Under $10 for Massive Upside Projections Nov 06 2016
Top Analyst Upgrades and Downgrades: Agrium, Array BioPharma, Encana, GoPro, 3D Systems and More Nov 04 2016
ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report Nov 03 2016
Edited Transcript of ARRY earnings conference call or presentation 1-Nov-16 1:00pm GMT Nov 01 2016
Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today Nov 01 2016
Array BioPharma reports 1Q loss Nov 01 2016
Array BioPharma reports 1Q loss Nov 01 2016
Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2017 Nov 01 2016
ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 01 2016
Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2017 Nov 01 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)